October 2026
Genetic and biochemical screens identify MGAT1 as a druggable glycosyltransferase target in STK11-mutant lung cancer
September 2026
Covalent and Non-Covalent Lead Generation Strategies for VRK1, a Paralog Synthetic Lethal Target in Cancer
July 2026
Mass Spectrometry-Based Kinetic and Site-Specific Profiling of Covalent Inhibitors Targeting VRK1
June 2026
Hit finding and assay enablement for MGAT1, a novel glycosyltransferase involved in cancer cell immune evasion
June 2026
TNG917 is a Potent and Selective Inhibitor of Histone Lysine Methyltransferases EHMT1/2 that Enhances Antitumor Immunity and Immunotherapy Efficacy
